Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05469490
Title Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Luke, Jason, MD
Indications
Therapies
Age Groups: senior | child | adult
Covered Countries


No variant requirements are available.